CTP of β-hCG Vaccine
Alternative Name: Carboxy Terminus Peptide of β-human chorionic gonadotropin
Description: Carboxy Terminus Peptide (CTP) of β-human chorionic gonadotropin (β-hCG) was a candidate immunogen to develop immunocontraceptive vaccine for human application.
Product Details
Status Details
Developer: ,
Status Details: - Phase I trial with a synthetic CTP vaccine was successfully conducted in Australia by the WHO Task Force on Vaccines for Fertility Regulation. Phase II trials were subsequently initiated in Sweden, but stopped due to unacceptable adverse reactions.
- Phase I trial with a synthetic CTP vaccine was successfully conducted in Australia by the WHO Task Force on Vaccines for Fertility Regulation. Phase II trials were subsequently initiated in Sweden, but stopped due to unacceptable adverse reactions.
Additional Information
References: Steven VC, et al. (1981) Preparation and formulation of a hCG antifertility vaccine: Selection of adjuvant and vehicle. Am J Reprod Immunol Microbiol. 6:315-21.
Steven VC, et al. (1981) Preparation and formulation of a hCG antifertility vaccine: Selection of adjuvant and vehicle. Am J Reprod Immunol Microbiol. 6:315-21.
Footnotes: - See also entry on β-hCG vaccine (non-CTP).
- See also entry on β-hCG vaccine (non-CTP).